Silencing myelin protein zero-like 1 expression suppresses cell proliferation and invasiveness of human glioma cells by inhibiting multiple cancer-associated signal pathways

Jansen, 2010, Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers, Lancet Neurol, 9, 717, 10.1016/S1474-4422(10)70105-8 Sun, 2017, Forkhead box P3 regulates ARHGAP15 expression and affects migration of glioma cells through the Rac1 signaling pathway, Cancer Sci, 108, 61, 10.1111/cas.13118 Cuddapah, 2013, Bradykinin- induced chemotaxis of human gliomas requires the activation of KCa3.1 and ClC-3, J Neurosci, 33, 1427, 10.1523/JNEUROSCI.3980-12.2013 Habela, 2009, Chloride accumulation drives volume dynamics underlying cell proliferation and migration, J Neurophysiol, 101, 750, 10.1152/jn.90840.2008 Cuddapah, 2014, A neurocentric perspective on glioma invasion, Nature Rev Neurosci, 15, 455, 10.1038/nrn3765 Joester, 2001, The structure and function of tenascins in the nervous system, Matrix Biol, 20, 13, 10.1016/S0945-053X(00)00136-0 Deng, 2019, Impact of preoperative Karnofsky Performance Scale (KPS) and American Society of Anesthesiologists (ASA) scores on perioperative complications in patients with recurrent glioma undergoing repeated operation, J Neurorestoratol, 7, 143, 10.26599/JNR.2019.9040015 Huang, 2019, 2018 yearbook of neurorestoratology, J Neurorestoratol, 7, 11, 10.26599/JNR.2019.9040003 Huang, 2020, The 2019 yearbook of neurorestoratology, J Neurorestoratol, 8, 1, 10.26599/JNR.2020.9040004 Zhao, 1998, Purification and cloning of PZR, a binding protein and putative physiological substrate of tyrosine phosphatase SHP-2, J Biol Chem, 273, 29367, 10.1074/jbc.273.45.29367 Kusano, 2008, Phosphorylation and localization of protein-zero related (PZR) in cultured endothelial cells, Endothelium, 15, 127, 10.1080/10623320802125250 Jia, 2014, Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma, Cell Res, 24, 204, 10.1038/cr.2013.158 Chen, 2019, MPZL1 promotes tumor cell proliferation and migration via activation of Src kinase in ovarian cancer, Oncol Rep, 42, 679 Beigbeder, 2017, MPZL1 forms a signalling complex with GRB2 adaptor and PTPN11 phosphatase in HER2-positive breast cancer cells, Sci Rep, 7, 10.1038/s41598-017-11876-9 Zannettino, 2003, Novel mesenchymal and haematopoietic cell isoforms of the SHP-2 docking receptor, PZR: identification, molecular cloning and effects on cell migration, Biochem J, 370, 537, 10.1042/bj20020935 Lund, 2006, Reduced glioma infiltration in Src-deficient mice, J Neurooncol, 78, 19, 10.1007/s11060-005-9068-y Summy, 2006, Treatment for advanced tumors: Src reclaims center stage, Clin Cancer Res, 12, 1398, 10.1158/1078-0432.CCR-05-2692 Stedt, 2012, Specific inhibition of Src kinase impairs malignant glioma growth in vitro and in vivo, Mol Ther Nucleic Acids, 1, e19, 10.1038/mtna.2012.13 Sherry, 2009, STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells, Stem Cells, 27, 2383, 10.1002/stem.185 Priester, 2013, STAT3 silencing inhibits glioma single cell infiltration and tumor growth, Neuro Oncol, 15, 840, 10.1093/neuonc/not025 Zielske, 2005, Importin 7 may be dispensable for human immunodeficiency virus type 1 and Simian immunodeficiency virus infection of primary macrophages, J Virol, 79, 11541, 10.1128/JVI.79.17.11541-11546.2005 Huse, 2010, Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma, Nat Rev Cancer, 10, 319, 10.1038/nrc2818 Taniguchi, 2014, IL-6 and related cytokines as the critical lynchpins between inflammation and cancer, Semin Immunol, 26, 54, 10.1016/j.smim.2014.01.001 Labbé, 2012, Protein tyrosine phosphatases in cancer: friends and foes!, Prog Mol Biol Transl Sci, 106, 253, 10.1016/B978-0-12-396456-4.00009-2 Huang, 2014, Structure, function, and pathogenesis of SHP2 in developmental disorders and tumorigenesis, Curr Cancer Drug Targets, 14, 567, 10.2174/1568009614666140717105001 Grossmann, 2010, The tyrosine phosphatase Shp2 in development and cancer, Adv Cancer Res, 106, 53, 10.1016/S0065-230X(10)06002-1 Reya, 2005, Wnt signalling in stem cells and cancer, Nature, 434, 843, 10.1038/nature03319 Clevers, 2006, Wnt/β-catenin signaling in development and disease, Cell, 127, 469, 10.1016/j.cell.2006.10.018 Chen, 2004, Up-regulation of Wnt-1 and β-catenin production in patients with advanced metastatic prostate carcinoma: Potential pathogenetic and prognostic implications, Cancer, 101, 1345, 10.1002/cncr.20518 Zhang, 2005, Effect of WNT-1 on β-catenin expression and its relation to Ki-67 and tumor differentiation in oral squamous cell carcinoma, Oncol Rep, 1095 Zhang, 2012, Wnt/beta-catenin signaling in glioma, J Neuroimmune Pharmacol, 7, 740, 10.1007/s11481-012-9359-y Wu, 2017, SOST silencing promotes proliferation and invasion and reduces apoptosis of retinoblastoma cells by activating Wnt/β-catenin signaling pathway, Gene Ther, 24, 399, 10.1038/gt.2017.31 Wolfenson, 2013, Dynamic regulation of the structure and functions of integrin adhesions, Dev Cell, 24, 447, 10.1016/j.devcel.2013.02.012 Demuth, 2004, Molecular mechanisms of glioma cell migration and invasion, J Neurooncol, 70, 217, 10.1007/s11060-004-2751-6 Zhou, 2014, Immunolocalization of MMP-2 and MMP-9 in human rheumatoid synovium, Int J Clin Exp Pathol, 7, 3048 Komatsu, 2004, Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas, Brain Tumor Pathol, 21, 105, 10.1007/BF02482184 Wang, 2003, The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades, Brain Tumor Pathol, 20, 65, 10.1007/BF02483449 Huang, 2005, Anticancer metal compounds in NCI’s tumor-screening database: putative mode of action, Biochem Pharmacol, 69, 1009, 10.1016/j.bcp.2005.01.001 Liu, 2013, Design, synthesis and evaluation of 1,2-benzisothiazol-3-one derivatives as potent caspase-3 inhibitors, Biorg Med Chem, 21, 2960, 10.1016/j.bmc.2013.03.075 Strasser, 2011, Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases, EMBO J, 30, 3667, 10.1038/emboj.2011.307 Bruyère, 2013, Targeting cyclin-dependent kinases in anti-neoplastic therapy, Curr Opin Cell Biol, 25, 772, 10.1016/j.ceb.2013.08.004 Vivanco, 2012, Differential sensitivity of glioma-versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors, Cancer Discov, 2, 458, 10.1158/2159-8290.CD-11-0284 Guha, 2019, Integrin-EGFR interaction regulates anoikis resistance in colon cancer cells, Apoptosis, 24, 958, 10.1007/s10495-019-01573-5 Sullivan, 2012, The p53 circuit board, Biochim Biophys Acta, 1825, 229 Zhang, 2019, LncRNA WT1-AS up-regulates p53 to inhibit the proliferation of cervical squamous carcinoma cells, BMC Cancer, 19, 10.1186/s12885-019-6264-2 Sabapathy, 2019, Understanding p53 functions through p53 antibodies, J Mol Cell Biol, 11, 317, 10.1093/jmcb/mjz010 Silvennoinen, 1993, Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation, Science, 261, 1736, 10.1126/science.8378775 Zhong, 1994, Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6, Science, 264, 95, 10.1126/science.8140422 Ruff-Jamison, 1994, Epidermal growth factor and lipopolysaccharide activate Stat3 transcription factor in mouse liver, J Biol Chem, 269, 21933, 10.1016/S0021-9258(17)31735-0 Wojcik, 2006, A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells, Oncogene, 25, 2773, 10.1038/sj.onc.1209306 Xie, 2004, Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis, Oncogene, 23, 3550, 10.1038/sj.onc.1207383 Mandal, 2014, Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2—protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells, Cell Signal, 26, 1725, 10.1016/j.cellsig.2014.04.003 Faruqi, 2001, Rac1 mediates STAT3 activation by autocrine IL-6, PNAS, 98, 9014, 10.1073/pnas.161281298 Senft, 2011, Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells, J Neurooncol, 101, 393, 10.1007/s11060-010-0273-y